Dr Reddy's Laboratories Reports a 2% Increase in Q3 PAT Amidst a 16% Revenue Surge
Dr Reddy’s Laboratories reports a 2% increase in Q3 PAT to Rs 1414.3 crore, with a 16% revenue surge to Rs 8,359 crore, driven by the NRT business and global generics growth, despi...
